TRiBECA® Knowledge
We are a London-based tech company working exclusively with pharmaceutical companies worldwide. We provide agile platforms that help our clients streamline processes and execute better in pipeline planning, launch readiness, market access, pricing, tender management and compliance. We innovate with our clients to deliver smart digital transformation.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Genetic Digital
We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…
Nmblr
From day-one concept to launch and beyond, Nmblr is the strategy and collaboration platform that partners with biopharma teams.
Company Details
Latest Content from PMHub
The digital reality check: How pharma measures up in 2025
White Papers and Resources | December 1, 2025 | Graphite Digital
Download your copy of our latest pharma white paper, exploring the latest digital trends, challenges and opportunities in pharma.
Behind the scenes: why we created ‘The participation equation’
White Papers and Resources | November 28, 2025 | Cuttsy + Cuttsy
Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research.
Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025
White Papers and Resources | November 28, 2025 | Inizio
As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...
Cuttsy+Cuttsy launches R:SQD – a new way to predict and improve trial success
Press Releases | November 27, 2025 | Cuttsy + Cuttsy
Cuttsy+Cuttsy has launched R:SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and improve participant engagement and trial outcomes.
Does real-world use of AI in systematic literature reviews result in time and cost savings?
White Papers and Resources | November 27, 2025 | Amiculum
By Manca Povsic and Emma Griffiths
How DataGateway unified oncology data for real-world insights & market intelligence
White Papers and Resources | November 26, 2025 | Inizio
Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.
Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.
Press Releases | November 26, 2025 | Inizio
Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.
ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement
White Papers and Resources | November 26, 2025 | Inizio
Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.
Is Joint Clinical Assessment (JCA) appropriate for assessing the broader value of vaccines?
White Papers and Resources | November 21, 2025 | Amiculum
By Emily Morton-West
The Future of MSL Training – How Digital Technologies Are Shaping Success
Press Releases | November 20, 2025 | Impetus Digital
Discover how pharmaceutical companies are using asynchronous platforms and microlearning to eliminate geographical barriers, track performance, and achieve cost-effective, consistent training for global teams.